MilliporeSigma has entered several agreements with Evotec AG, under which Evotec will provide screening services for Merck’s genetic reagents such as CRISPR and shRNA libraries. Combining access to these libraries with Evotec’s screening expertise aims to offer an accelerated pathway to explore and identify new drug targets.     The collaboration allows customers to select a customized set of CRISPR and shRNA libraries, and then leverage Evotec’s phenotypic screening within p...